Physician profile
Ryan A Hueter
NPI 1194967414
$859.31
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $129 · 2021: $29.21 · 2022: $15.99 · 2023: $56.39 · 2024: $17.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $73.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $73.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $96.32 | 2019-2020 | |
| Pfizer INC. | $85.72 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $84.08 | 2019 | |
| Genentech USA, INC. | $70.67 | 2019-2022 | |
| Glaxosmithkline, LLC. | $62.53 | 2019 | |
| Amgen INC. | $59.17 | 2019-2020 | |
| Allergan, INC. | $58.63 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $47.29 | 2019 | |
| Novo Nordisk INC | $43.38 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.56 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $38.67 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.48 | 2019-2020 | |
| Insulet Corporation | $22.44 | 2019 | |
| Amneal Pharmaceuticals LLC | $20.11 | 2020 | |
| Gilead Sciences, INC. | $19.56 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $18.62 | 2020 | |
| Therapeuticsmd, INC. | $16.50 | 2019 | |
| Kaleo, INC. | $15.77 | 2019 | |
| Ironshore Pharmaceuticals INC. | $13.34 | 2019 | |
| Merck Sharp & Dohme LLC | $12.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Hueter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.